Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge
M Nedeljković, A Damjanović - Cells, 2019 - mdpi.com
Triple-negative (TNBC) is the most lethal subtype of breast cancer owing to high
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
heterogeneity, aggressive nature, and lack of treatment options. Chemotherapy remains the …
The multi-factorial nature of clinical multidrug resistance in cancer
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …
MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review
SR Volovat, C Volovat, I Hordila, DA Hordila… - Frontiers in …, 2020 - frontiersin.org
Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
Recent treatment progress of triple negative breast cancer
Y Chang-Qing, L Jie, Z Shi-Qi, Z Kun, G Zi-Qian… - Progress in biophysics …, 2020 - Elsevier
Breast cancer (BC) is a serious worldwide disease that threatens women's health.
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …
Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC
Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high
incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline …
incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline …
Roles of miRNA and IncRNA in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast
cancer without effective targeted therapies, which makes its pathogenesis an important …
cancer without effective targeted therapies, which makes its pathogenesis an important …
MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer
L Ding, H Gu, X Xiong, H Ao, J Cao, W Lin, M Yu, J Lin… - Cells, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity
M Ashrafizadeh, A Zarrabi, S Orouei… - European Journal of …, 2021 - Elsevier
Chemoresistance has doubled the effort needed to reach an effective treatment for cancer.
Now, scientists should consider molecular pathways and mechanisms involved in …
Now, scientists should consider molecular pathways and mechanisms involved in …
Triple negative breast cancer in the era of miRNA
The objective of this review is to elucidate the role of miRNAs in triple negative breast cancer
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …
The emerging role of miRNA clusters in breast cancer progression
Micro RNAs (miRNAs) are small non-coding RNAs that are essential for regulation of gene
expression of the target genes. Large number of miRNAs are organized into defined units …
expression of the target genes. Large number of miRNAs are organized into defined units …